Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot arm helps stroke survivors move again

NCT ID NCT05251077

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a robotic system called Harmony SHR to help people who had a stroke and have trouble moving one or both arms. The robot assists with shoulder and arm movements during rehab. The goal was to see if it is safe, reliable, and helpful for improving arm function. The study included 21 patients in a rehab hospital.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Jan 2022

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Limited or impaired functional use of one or both upper extremities due to stroke * Currently admitted to the Shirley Ryan AbilityLab as an inpatient * Minimum passive Range of Motion requirements as follows: * Shoulder flexion: 90⁰ minimum with zero starting point of arm perpendicular to the floor and 90⁰ measuring at a right angle parallel to the floor in the sagittal plane * Shoulder abduction: 90⁰ minimum with zero starting point of arm perpendicular to the floor and 90⁰ measuring at a right angle parallel to the floor in the coronal/frontal plane * Shoulder rotation: tolerating of don/doff position, depending on the degree of ER required for that position * Elbow flexion: 90⁰ minimum with zero starting point of arm perpendicular to the floor and 90⁰ measuring at a right angle parallel to the floor in the sagittal plane * Wrist pronation: 0⁰ minimum with the zero starting point of the forearm in neutral with the palm of the hand pointing inward and the thumb pointing up, perpendicular to the floor * Have skeletal measurements within the ranges specified: * Seated shoulder height in range of 840 mm to 1122 mm measured as the sum of the following: * Seat of chair to acromion process of seated patient * Height of the chair * Shoulder Breadth in the range of 324mm to 443mm measured between the acromion process in one scapula to the acromion process on the other scapula * Humeral length in the range of 250mm to 350mm measured between the greater tubercle to lateral epicondyle * Ulnar length in the range of 228 mm to 306 mm measured between the olecranon to head of ulna/styloid process * 21 years of age or older * Ability to safely transfer from mobility device to standard chair with no armrests or with the assistance of a licensed occupational therapist/trained research staff * Able and willing to give written consent and comply with study procedures Exclusion Criteria: * Pregnant * Pressure injury or exposed broken skin at sites of contact with device * History of mastectomy and/or axillary lymph node resection or history of active lymphedema in upper extremity * Recent sternotomy/active sternal precautions * Recent pacemaker/ICD placement with active pacemaker precautions * Inability to tolerate upright position and traditional therapy outside of the device * Spasticity \>3 on the Modified Ashworth Scale (MAS) * Medical line (e.g., IV, PICC, dialysis port) at contact points * Heterotrophic ossification * Unresolved deep vein thrombosis * Fixed joint contractures that limit movement required to use device * Inability to express pain/discomfort * Presence of a condition that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke, acute are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60661, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.